The "Compliance Trap": Is Your R&D Process Leaving Money on the Table?

Banned ingredients, dye phase-outs, and new labeling rules arrive with hard deadlines. Luna's domain-trained AI searches every compliant combination and trade-off, so you don't just meet the regulation — you emerge with a better product than the one you started with.

Why "Good Enough" is No Longer Good Enough

In a volatile market, the "just enough" fix is a silent killer of profitability. Every time formulators manually balance dozens of variables, they trade something away — and the losses compound.

Margin Erosion

You solve for compliance, but a more expensive ingredient quietly shrinks the margin on every unit you ship.

Performance Hits

The formula is compliant, but loyal customers notice the change in taste, texture, or efficacy — and they switch.

Innovation Gridlock

Your best R&D talent is trapped on defensive reformulation instead of creating the next blockbuster product.

Competitive Lag

While you reformulate by hand, faster competitors reach the shelf first and capture the share and loyalty you lose.

Escape the Trap. Turn Compliance into a Competitive Advantage.

Luna flips the equation. Instead of trading margin for compliance, it explores the full solution space to find formulas that stay compliant, protect performance, and defend your margins at the same time.

Win Market Share Through Speed

Reformulate at scale 10x faster than manual R&D. When regulations change or preferences shift, reach the shelf first with a compliant, optimized product.

De-Risk Your Formula

Luna explores the full solution space and validates compliance and performance before the bench — so loyal customers never notice a compromise.

Unlock Hidden Margins

Surface lower-cost, compliant formulations that hold quality — turning every forced reformulation into a margin opportunity instead of a loss.

Accelerate Innovation

Automate the defensive reformulation work so your best scientists spend their time creating the next category-defining product, not firefighting.

Take the 90-Second Shelf Risk Audit.

These compromises create measurable risks. Answer 7 questions to see your R&D Risk Score and identify your most critical vulnerabilities.

Thought leadership from the team rewriting R&D

Our founder & CEO on why “good enough” reformulation will sink CPG leaders by 2028 — and the playbook to turn compliance into a competitive weapon.

Escaping The Compliance Trap: Why “Good Enough” Reformulation Will Sink CPG Leaders By 2028

Manmit Shrimali, Founder & CEO, Turing Labs

Consumer packaged goods companies are facing the largest recipe rewrite in decades. From the FDA’s ban on brominated vegetable oil to upcoming bans on additives and dyes in states such as California, Illinois and Virginia, the regulatory tsunami is only beginning — and it’s coming faster than most R&D teams can handle.

“That’s the compliance trap — when ‘good enough’ works for now, but sets companies up for failure in future markets.”

On the surface, the trap looks like success: “We complied!” In reality, it’s margin leakage, brand dilution and missed innovation — SKU by SKU, quarter after quarter, while competitors build faster, healthier portfolios.

The R&D Resilience Playbook

Escaping this trap requires a fundamental shift from reactive, SKU-by-SKU fixes to proactive, portfolio-level optimization. Here’s the playbook to follow:

1. Audit your portfolio exposure
   Map every SKU against upcoming deadlines — BVO (2025), additives bans (2027) and “healthy” criteria (2028). Quantify the hidden costs of past reformulations: margin hits, consumer complaints and lost claims. This creates a true “shelf risk score.”

2. Break the silos
   Reformulation isn’t an R&D-only problem. Compliance deadlines demand cross-functional mandates, with R&D, marketing, regulatory, supply chain and finance teams aligned from day one. Define success across the company as more than just “compliance.”

3. Move from SKU to portfolio optimization
   Manual swaps don’t scale. You need multiconstraint optimization that balances cost, compliance and supply at the portfolio level. AI platforms can model thousands of scenarios in hours instead of months, turning constraints into options.

4. Build compounding capability
   Every reformulation should make the next one faster. Capture learnings, data and ingredient trade-offs into a reusable system. Over time, your R&D agility compounds, turning regulation into a speed advantage competitors can’t match.

“Are you trapped in ‘good enough’? Or are you ready to turn reformulation into your next competitive weapon?”

Manmit Shrimali — Founder & CEO, Turing Labs

Ready to Build a More Resilient R&D Process?

A high risk score isn't a verdict—it's an opportunity. Let us show you how the Turing engine can directly address the vulnerabilities you've identified and turn your reformulation process into a powerful engine for growth.